Osmetech prolongs trading with £5m share placing and Gleeson backing
This article was originally published in Clinica
Executive Summary
Molecular diagnostics firm Osmetech is to boost its dwindling cash reserves by raising £5.1m ($8.4m) through a share placement with new and existing investors.